Logo

Biodesix Receives BCBS Coverage for VeriStrat

Apr 22, 2015 | staff reporter

NEW YORK (GenomeWeb) – Biodesix today announced that its VeriStrat test has received a positive coverage decision from CareFirst Blue Cross Blue Shield.

VeriStrat is a blood-based proteomic test that helps guide treatment decisions for patients with non-small cell lung cancer.

CareFirst announced its position to extend coverage for the VeriStrat test in March and published a positive coverage policy earlier this week on its website, Biodesix said.

"This decision is great news for CareFirst BCBS' members who can now be confident of coverage when their physicians choose VeriStrat to help guide their treatment decisions," Biodesix CEO David Brunel said in a statement.

A study sponsored by the firm and published in March in the journal Lung Cancer found that the test decreased total lifetime direct cost by $135 per patient.

CareFirst covers 3.4 million patients in Maryland, the District of Columbia, and parts of Virginia.

Filed under

Cancer
Molecular Diagnostics
Reimbursement News
Proteomics & Protein Research
non-small cell lung cancer
Biodesix
Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.